The latest episode of Coffee Talk sees co-chairs of the ERS Clinical Research Collaboration CADSET, Prof. Erik Melén and Prof. Rosa Faner, catch up to discuss the topic of the new lung function tracker tool.
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous condition. We hypothesized that the unbiased integration of different COPD lung omics using a novel multi-layer approach may unravel mechanisms associated with clinical characteristics.
Insight into the impact of doxycycline in therapeutic trials for COPD, emphasizing the need for careful microbiological monitoring in future interventional trials in patients with COPD
In the general population Persistent Airflow Obstruction (PAO) was largely mild but there are significant phenotypic differences between young and old individuals with PAO
Uncover the prevalence, characteristics, and comorbidities of asthma with airflow obstruction (AFO) in adults over 50. Learn how AFO compares to asthma-only and COPD-only in this comprehensive study.
Some patients with COPD suffer frequent exacerbations (FE). We hypothesised that their systemic proteomic profile would be different from that of non-frequent exacerbators (NFE).
The prevalence and diagnostic utility of bronchodilator responsiveness (BDR) in a real-life setting is unclear. Objective: To explore this uncertainty
The diagnosis of COPD requires the demonstration of non-fully reversible airflow limitation by spirometry in the appropriate clinical context.
The COPD Foundation is kicking off its 20th anniversary year with exciting news! Bronchiectasis and NTM 360, a division of the COPD Foundation, is thrilled to announce its journey to establish a Bronchiectasis and NTM Care Center Network.
The treatable traits approach represents a strategy for patient management. It is based on the identification of characteristics susceptible to treatments or predictive of treatment response in each individual patient.
